Image Coming Soon
Brain-Based Sexual Enhancement
PT-141 is a revolutionary peptide that works through the central nervous system to enhance sexual desire and arousal. FDA-approved for women (Vyleesi) and used off-label for men, it addresses both libido and physical response where traditional ED medications may fall short.
PT-141 requires medical evaluation to ensure it's appropriate for your health profile. Our physicians will review your cardiovascular health, current medications, and discuss your treatment goals to create a personalized protocol that maximizes benefits while minimizing side effects.
Our discreet telehealth process makes it easy to address sexual wellness concerns.
Book a private virtual consultation with one of our physicians.
Discuss your sexual health concerns and review your medical history.
Receive your PT-141 protocol with dosing instructions.
Your peptide ships discreetly to your home.
FDA approved Bremelanotide (Vyleesi) in 2019 for women with hypoactive sexual desire disorder (HSDD).
Studies show PT-141 produces statistically significant erectile response in men at doses exceeding 7mg, with effects beginning roughly 30 minutes after administration.
Combination studies with sildenafil showed "clinically significant enhanced erectile response" in men who were inadequate responders to sildenafil alone.
PT-141 (Bremelanotide) is a synthetic peptide that activates melanocortin receptors in the brain to enhance sexual desire and arousal. Unlike traditional ED medications that work on blood flow, PT-141 works through the central nervous system to address both desire and physical response.
While Viagra and similar PDE5 inhibitors work by increasing blood flow to the genitals, PT-141 works in the brain by stimulating melanocortin receptors and increasing dopamine production. This means it addresses both sexual desire (libido) and physical arousal, making it effective for people who don't respond to traditional ED medications.
PT-141 is typically administered via subcutaneous injection or nasal spray approximately 30-60 minutes before sexual activity. The injection is given in the abdomen or thigh. Your physician will provide detailed instructions and training.
PT-141 typically takes effect within 30-60 minutes after administration. The effects can last several hours, and it should be used on an as-needed basis rather than daily.
The most common side effect is nausea, which occurs in approximately 40% of patients but is typically mild and temporary. Flushing is also common but usually brief and mild. These side effects tend to decrease with continued use.
PT-141 (branded as Vyleesi) was FDA approved in 2019 for treating hypoactive sexual desire disorder (HSDD) in women. For men, its use is currently off-label but supported by clinical research showing effectiveness for erectile dysfunction.
Schedule your confidential telehealth consultation today. Our physicians will determine if PT-141 is right for your sexual wellness goals.